Literature DB >> 19059833

Bullous pemphigoid followed by pustular psoriasis showing Th1, Th2, Treg and Th17 immunological changes.

Shinsuke Yasukawa1, Teruki Dainichi, Hisashi Kokuba, Yoichi Moroi, Kazunori Urabe, Takashi Hashimoto, Masutaka Furue.   

Abstract

Psoriasis vulgaris is occasionally accompanied by autoimmune bullous diseases, but the opposite is very rare. We document here the first reported case of generalized pustular psoriasis that appeared during steroid therapy for bullous pemphigoid. The serum cytokine levels and the results of an immunohistochemical study over the disease course suggest that the immunological state was consistent with a shift from Th2-dominance to Th1-dominance. IL-17-producing cells appeared in the skin lesions when each disease was most exacerbated and disappeared after remission. Thus, the present case demonstrated a dynamic immunological state in which the appearances of Th1 and Th2 as well as Th17 varied during the course of the disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19059833     DOI: 10.1684/ejd.2008.0572

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  5 in total

1.  A gene network bioinformatics analysis for pemphigoid autoimmune blistering diseases.

Authors:  Antonio Barone; Paolo Toti; Maria Rita Giuca; Giacomo Derchi; Ugo Covani
Journal:  Clin Oral Investig       Date:  2014-11-08       Impact factor: 3.573

2.  T lymphocyte subset imbalances in patients contribute to ankylosing spondylitis.

Authors:  Chenggong Wang; Qiande Liao; Yihe Hu; DA Zhong
Journal:  Exp Ther Med       Date:  2014-11-04       Impact factor: 2.447

3.  Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study.

Authors:  Shigetoshi Sano; Hiroshi Kubo; Hitomi Morishima; Ryosuke Goto; Richuan Zheng; Hidemi Nakagawa
Journal:  J Dermatol       Date:  2018-03-22       Impact factor: 4.005

Review 4.  Interaction of Psoriasis and Bullous Diseases.

Authors:  Teruki Dainichi; Kenji Kabashima
Journal:  Front Med (Lausanne)       Date:  2018-08-08

5.  Bullous Pemphigoid in Patients Receiving Immune-Checkpoint Inhibitors and Psoriatic Patients-Focus on Clinical and Histopathological Variation.

Authors:  Dennis Niebel; Dagmar Wilsmann-Theis; Thomas Bieber; Mark Berneburg; Joerg Wenzel; Christine Braegelmann
Journal:  Dermatopathology (Basel)       Date:  2022-03-18
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.